364 related articles for article (PubMed ID: 28526632)
21. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia.
Rotker KL; Alavian M; Nelson B; Baird GL; Miner MM; Sigman M; Hwang K
Asian J Androl; 2018; 20(2):195-199. PubMed ID: 29205178
[TBL] [Abstract][Full Text] [Related]
22. Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice.
Rhoden EL; Morgentaler A
J Sex Med; 2010 Jan; 7(1 Pt 1):277-83. PubMed ID: 20104673
[TBL] [Abstract][Full Text] [Related]
23. Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.
Lazarou S; Morgentaler A
Curr Urol Rep; 2005 Nov; 6(6):476-81. PubMed ID: 16238923
[TBL] [Abstract][Full Text] [Related]
24. Androgen deficiency in aging and metabolically challenged men.
Shelton JB; Rajfer J
Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
[TBL] [Abstract][Full Text] [Related]
25. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
Traish AM
Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
[TBL] [Abstract][Full Text] [Related]
26. Testosterone administration in older men.
Matsumoto AM
Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
[TBL] [Abstract][Full Text] [Related]
27. Risks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden EL; Morgentaler A
N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
[No Abstract] [Full Text] [Related]
28. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
[TBL] [Abstract][Full Text] [Related]
29. The truth about testosterone replacement therapy. Fountain of youth--or harbinger of health woes?
Johns Hopkins Med Lett Health After 50; 2014 Jun; 29(5):1-2. PubMed ID: 25097952
[No Abstract] [Full Text] [Related]
30. Androgen Therapy in Male Patients Suffering from Type 2 Diabetes: A Review of Benefits and Risks.
Hassanabad MF; Fatehi M
Curr Diabetes Rev; 2020; 16(3):189-199. PubMed ID: 30073928
[TBL] [Abstract][Full Text] [Related]
31. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
Johansen KL
Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
[TBL] [Abstract][Full Text] [Related]
32. Emerging medication for the treatment of male hypogonadism.
Aydogdu A; Swerdloff RS
Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
[TBL] [Abstract][Full Text] [Related]
33. Is testosterone therapy safe? Take a breath before you take the plunge. Understand the potential risks and consider alternatives before boosting your hormones indefinitely.
Harv Mens Health Watch; 2014 Feb; 18(7):1, 7. PubMed ID: 24818282
[No Abstract] [Full Text] [Related]
34. A new testosterone gel (fortesta) for hypogonadism.
Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine.
Morgentaler A; Traish A; Hackett G; Jones TH; Ramasamy R
Sex Med Rev; 2019 Oct; 7(4):636-649. PubMed ID: 31351915
[TBL] [Abstract][Full Text] [Related]
36. Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy.
Schumacher KA; Gosmanov AR
J Investig Med High Impact Case Rep; 2022; 10():23247096221111774. PubMed ID: 35848311
[TBL] [Abstract][Full Text] [Related]
37. Testosterone: A Review for Orthopaedic Surgeons.
Arcand MA; Poulin D; Testa EJ; Lemme NJ
JBJS Rev; 2024 Jun; 12(6):. PubMed ID: 38889232
[TBL] [Abstract][Full Text] [Related]
38. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.
Zitzmann M; Mattern A; Hanisch J; Gooren L; Jones H; Maggi M
J Sex Med; 2013 Feb; 10(2):579-88. PubMed ID: 22812645
[TBL] [Abstract][Full Text] [Related]
39. Reversible aquagenic pruritus associated with testosterone-induced erythrocytosis.
Liu M; Shinkai K
J Am Acad Dermatol; 2014 Jun; 70(6):e139-40. PubMed ID: 24831338
[No Abstract] [Full Text] [Related]
40. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Letter.
Kaplan-Marans E
J Urol; 2022 Sep; 208(3):566-567. PubMed ID: 35648648
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
